The number and percentages of tender joints at baseline, and after 12 and 24 weeks of treatment as a function of the scintigraphic status at baseline
| Scintigraphic negative | Scintigraphic positive | OR | p Value | |||||
|---|---|---|---|---|---|---|---|---|
| All patients | No tenderness | Tenderness | No tenderness | Tenderness | ||||
| Tender joints at baseline | 1057 (91.8%) | 95 (8.2%) | 94 (56.3%) | 73 (43.7%) | 8.60 | <0.001 | ||
| Not tender anymore at w12 or w24 | Remains tender at w12 or w24 | Not tender anymore at w12 or w24 | Remains tender at w12 or w24 | |||||
| Tender joints at w12 | 69 (72.6%) | 26 (27.4%) | 58 (79.5%) | 15 (20.5%) | 0.69 | 0.309 | ||
| Tender joints at w24 | 65 (68.4%) | 30 (31.6%) | 64 (87.7%) | 9 (12.3%) | 0.30 | 0.004 | ||
w12, week 12; w24, week 24.